Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Innovotech Inc. (V:IOT)

Business Focus: Pharmaceuticals

Log in or join to add this stock to your watch list.
Aug 20, 2019 02:08 am ET
Innovotech Inc Reports 3 and 6-month Results to June 30, 2019
Edmonton – TheNewswire - August 20, 2019. Innovotech Inc. (TSXV:IOT), a leader in contract research in connection with the susceptibility of medical devices to microbial biofilm formations, has released its financial and operating results for the three and six-month periods ended June 30, 2019.
Jul 29, 2019 07:07 am ET
Innovotech Reports Notice of Allowance of a US Patent for Antimicrobial Silver Iodates in Gels
Edmonton – TheNewswire - July 26, 2019.  Innovotech Inc. (TSXV:IOT), is pleased to report that it has received Notice of Allowance of a US patent (14/415,666) for its silver compounds, including InnovoSIL™-1 and AgreGuard™-1, which have broad activity against pathogens causing both bacterial and fungal infections.
Jul 19, 2019 02:07 am ET
Innovotech Reports on Changes to its Board of Directors
Edmonton, AB – TheNewswire - July 19, 2019 - Innovotech Inc. (TSXV:IOT) advises that Dr. Wolfgang Muhs has retired from the Board of Directors of the Company after many years of contributive and committed service to the Board and to Shareholders.  All of us at Innovotech thank him and wish him only the best of all things ahead.
Jul 15, 2019 02:07 am ET
Innovotech Reports Amended Terms of Line of Credit, Comments on Business Activity
Edmonton, AB – TheNewswire - July 15, 2019 - Innovotech Inc. (TSXV:IOT), is pleased to report that the 6% $100,000 working capital loan advanced by a shareholder, which is currently payable on October 22, 2019, has, by agreement, been amended to a 3-year term note maturing on July 15th, 2022.  The new terms will have a positive effect on the Company’s working capital.  These terms allow for the loan to be paid in whole or in part at any time during its period to maturity.  There was no consideration paid for the improved terms agreed with the shareholder.